Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben Sprangers

Showing results (51-60 of 182) with videos related to

Pageof 19
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 11, 2015
Onco-nephrology: Core Curriculum 2015Eric P Cohen, Jean-Marie Krzesinski, Vincent Launay-Vacher, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 24, 2024
Cancer therapy in patients with reduced kidney functionSabine Karam, Mitchell H Rosner, Ben Sprangers, et al.
Journal of Immunology Research|October 3, 2018
OSU-T315 as an Interesting Lead Molecule for Novel B Cell-Specific TherapeuticsKristien Van Belle, Jean Herman, Mark Waer, et al.
Nature Clinical Practice. Oncology|June 29, 2007
Experimental and clinical approaches for optimization of the graft-versus-leukemia effectBen Sprangers, Bart Van Wijmeersch, Sabine Fevery, et al.
Immunopharmacology and Immunotoxicology|March 24, 2021
Prolongation of allograft survival by artemisinin treatment is associated with blockade of OX40-OX40LLihua Liu, Juanzhi Zhao, An Li, et al.
Journal of Leukocyte Biology|June 17, 2020
Artemisinin attenuates IgM xenoantibody production via inhibition of T cell-independent marginal zone B cell proliferationLihua Liu, Juanzhi Zhao, An Li, et al.
Clinical Kidney Journal|May 2, 2022
Treatment of acute kidney injury in cancer patientsPauline Braet, Giulia Vanessa Re Sartò, Marta Pirovano, et al.
Acta Neurologica Belgica|December 1, 2017
Management of adverse renal events related to alemtuzumab treatment in multiple sclerosis: a Belgian consensusBen Sprangers, D Decoo, D Dive, et al.
Journal of Neuroimmunology|June 11, 2008
Autologous and allogeneic hematopoietic stem cell transplantation for Multiple Sclerosis: perspective on mechanisms of actionBart Van Wijmeersch, Ben Sprangers, Bénédicte Dubois, et al.
European Journal of Cancer (Oxford, England : 1990)|May 4, 2020
How to determine kidney function in cancer patients?Ben Sprangers, Ala Abudayyeh, Sheron Latcha, et al.
Pageof 19

Showing results (51-60 of 182) with videos related to

Sort By:
Pageof 19
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 11, 2015
Onco-nephrology: Core Curriculum 2015Eric P Cohen, Jean-Marie Krzesinski, Vincent Launay-Vacher, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 24, 2024
Cancer therapy in patients with reduced kidney functionSabine Karam, Mitchell H Rosner, Ben Sprangers, et al.
Journal of Immunology Research|October 3, 2018
OSU-T315 as an Interesting Lead Molecule for Novel B Cell-Specific TherapeuticsKristien Van Belle, Jean Herman, Mark Waer, et al.
Nature Clinical Practice. Oncology|June 29, 2007
Experimental and clinical approaches for optimization of the graft-versus-leukemia effectBen Sprangers, Bart Van Wijmeersch, Sabine Fevery, et al.
Immunopharmacology and Immunotoxicology|March 24, 2021
Prolongation of allograft survival by artemisinin treatment is associated with blockade of OX40-OX40LLihua Liu, Juanzhi Zhao, An Li, et al.
Journal of Leukocyte Biology|June 17, 2020
Artemisinin attenuates IgM xenoantibody production via inhibition of T cell-independent marginal zone B cell proliferationLihua Liu, Juanzhi Zhao, An Li, et al.
Clinical Kidney Journal|May 2, 2022
Treatment of acute kidney injury in cancer patientsPauline Braet, Giulia Vanessa Re Sartò, Marta Pirovano, et al.
Acta Neurologica Belgica|December 1, 2017
Management of adverse renal events related to alemtuzumab treatment in multiple sclerosis: a Belgian consensusBen Sprangers, D Decoo, D Dive, et al.
Journal of Neuroimmunology|June 11, 2008
Autologous and allogeneic hematopoietic stem cell transplantation for Multiple Sclerosis: perspective on mechanisms of actionBart Van Wijmeersch, Ben Sprangers, Bénédicte Dubois, et al.
European Journal of Cancer (Oxford, England : 1990)|May 4, 2020
How to determine kidney function in cancer patients?Ben Sprangers, Ala Abudayyeh, Sheron Latcha, et al.
Pageof 19